Blockade of K+ channels in insulin-secreting cells by the 'potassium channel opener' SDZ PCO 400.
Harding, E A
Blockade of K+ channels in insulin-secreting cells by the 'potassium channel opener' SDZ PCO 400. [electronic resource] - Biochemical Society transactions Nov 1993 - 402S p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0300-5127
10.1042/bst021402s doi
Animals
Benzopyrans--pharmacology
Cell Membrane--drug effects
Cyclopentanes--pharmacology
Diazoxide--pharmacology
In Vitro Techniques
Insulin--metabolism
Insulin Secretion
Islets of Langerhans--drug effects
Membrane Potentials--drug effects
Phentolamine--pharmacology
Potassium Channel Blockers
Potassium Channels--physiology
Rats
Tolbutamide--pharmacology
Blockade of K+ channels in insulin-secreting cells by the 'potassium channel opener' SDZ PCO 400. [electronic resource] - Biochemical Society transactions Nov 1993 - 402S p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0300-5127
10.1042/bst021402s doi
Animals
Benzopyrans--pharmacology
Cell Membrane--drug effects
Cyclopentanes--pharmacology
Diazoxide--pharmacology
In Vitro Techniques
Insulin--metabolism
Insulin Secretion
Islets of Langerhans--drug effects
Membrane Potentials--drug effects
Phentolamine--pharmacology
Potassium Channel Blockers
Potassium Channels--physiology
Rats
Tolbutamide--pharmacology